Chapter 54: Drugs Acting on the Upper Respiratory Tract

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive.

Today we are getting right into Chapter 54 from our source material, Drugs Acting on the Upper Respiratory Tract.

And this is really essential stuff.

We're going to break down the five core classes of meds that basically keep our airways open and working.

So our mission today really is to give you a functional shortcut.

We want you to understand not just what these drugs do, but how they do it, the mechanism of action, and more importantly, the nursing considerations for these medications that are, you know, everywhere.

They really are.

And to get started, we need a solid foundation.

Let's define our five pharmacological pillars.

Think of them as five essential tools in the respiratory toolbox.

First up, you have your antihistamines.

They block histamine, that chemical that causes all the swelling and sneezing in an allergic reaction.

It blocks the allergy.

Exactly.

Then number two, antitussives.

These are cough suppressants.

They literally block the cough reflex.

Third,

decongestants.

They cause vasoconstriction, so they shrink those swollen membranes and dry things up.

Fourth are the expectorants.

They do the opposite in a way.

They make your cough more productive by thinning out secretions.

So they help you cough things up.

Right.

And finally, mucolytics.

These are the heavy duty ones.

They're designed to break down really thick, stubborn mucus.

Okay, but before we dive into the first class, we have to talk about the biggest trap with these drugs.

Rebound congestion.

Yes.

The technical term is rhinitis medicamentosa, and it is such a vicious cycle.

How does that actually happen?

Well, a patient uses a topical decongestant spray, right, and they get instant relief.

But when the drug wears off, the body overcompensates.

You get this massive vasodilation, and the congestion comes roaring back even worse than before.

So they use the spray again.

They have to.

And that cycle can start in just, I mean, three to five days of over use.

We have to warn our patients about this.

Okay, that's a huge point.

Let's unpack that first class now.

Antitussives.

So these are for those really annoying, unproductive coughs you get with a cold.

But the big rule is if a cough is persistent, you have to find out why before you just suppress it.

100%.

And they work in two main ways.

Most are centrally acting.

So they go to the brain and they depress the cough center in the medulla.

Okay, so that's drugs like codeine, hydrocodone, and dextromethorphan, which is in almost everything over the counter.

Exactly.

They're all hitting that off switch in the brain.

And the other way.

That's the locally acting ones like benzonatate.

It works like a local anesthetic.

It just, it numbs the stretch receptors in the respiratory passages that are telling your brain to cough.

So it never even sends the signal.

It stops the signal right at the source.

And that leads right into the biggest contraindication.

You absolutely do not give an antitussive to a patient who needs to cough to keep their airway clear.

Like a post -op patient, abdominal or thoracic surgery.

Precisely.

If they can't cough up secretions, you're risking major complications.

Same goes for patients with asthma or emphysema.

Accumulating secretions is already a huge danger for them.

And what about interactions?

The centrally acting ones, they're working in the brain.

So you can get some CNS depression, drowsiness, sedation.

Yeah.

And the drying effects too.

Dry mouth, constipation.

But the really dangerous one is dextromethorphan with MAO inhibitors, right?

That's a life -threatening combination.

You can see extremely high fever, severe hypotension, even coma.

It's a huge risk for serotonin syndrome.

You just don't mix them.

And this ties right into a major lifespan alert from the text box 54 .1.

Cough in cold meds should not be used in kids under four, period.

And with extreme caution for kids between four and six.

Because parents might accidentally overdose them.

Yes.

They'll give them a cough syrup and an allergy medicine, not realizing they both have the same active ingredients.

We have to teach them to read every single label.

That's a perfect transition to our second class,

decongestants.

We've suppressed the cough, but now we need to deal with all the swelling and mucus.

Right.

And these are mostly adrenergic or sympathomimetics.

They mimic the fight or flight response.

They cause vasoconstriction.

They shrink everything down.

Exactly.

And you can deliver them topically or orally.

The topical nasal decongestants like oxymethazoline work almost instantly.

Ah, but there's the catch.

There's the catch.

That immediate relief comes with that huge risk of rebound congestion.

Use it for more than three to five days and you're almost certainly going to get trapped in that cycle.

And teaching proper technique is so important here.

The text mentions this in box 54 .2.

The patient should be sitting upright, head tilted back and sprayed gently.

You don't want them squeezing the bottle so hard it shoots up into their sinuses.

No, definitely not.

And you also need to check for any sores or lesions inside the nose because that could let the drug get absorbed systemically.

Which brings us to the side effects.

Even with a topical, you can get systemic effects, especially in high risk patients, increased heart rate, higher blood pressure.

Right.

Because it's mimicking adrenaline.

So any one of the glaucoma, hypertension, thyroid issues, heart disease,

you have to be so careful.

Now, when we switch to the oral decongestants like pseudoephedrine, the action is similar.

But it's systemic from the get go.

Exactly.

So those side effects we just talked about, they're much more likely.

You'll see anxiety, restlessness,

tremors, palpitations, high blood pressure.

And this is the stuff that's now kept behind the counter, right?

Because it can be used to make meth.

That's right.

The text points this out in box 54 .3.

After they pulled PPA from the market, pseudoephedrine became the main one, but it's highly regulated now for that very reason.

Which really highlights the key implementation point for us.

Tell patients to read the labels.

So many OTC cold products have pseudoephedrine in them, and it's incredibly easy to accidentally overdose by taking two different products at the same time.

You're stacking the same powerful stimulant without even knowing it.

The third strategy here is the topical nasal steroids, fluticasone, flunosalide.

These are for more chronic issues like allergic rhinitis.

They're not at all.

You have to tell them you won't feel relief for a few days, maybe even a week.

If nothing changes after three weeks, they should stop taking it.

Managing that expectation is key.

Absolutely.

And because steroids block the immune response, you don't use them if there's an active infection.

You could actually make it worse.

We even see an increased risk of Candida albicans, like a yeast infection, in the nose.

And that leads to a bigger systemic risk, doesn't it?

It does.

Patients using these should actively avoid people with airborne infections, like chicken pox or measles.

Their immune response is dampened, even from just a topical steroid.

Okay, let's pivot to our third class, antihistamines.

These are the ones that block histamine at the H1 receptor sites to stop that allergic response.

And the generational difference is everything here.

First generation,

like divinhydramine.

Benadryl.

Benadryl.

It crosses the blood -brain barrier easily, which is why it causes so much drowsiness and

The critical thinking scenario in the text with K .E., the businessman, is such a perfect example of why this matters.

He's just trying to get through his cold, taking multiple OTC products, and ends up with severe dizziness and drowsiness because he's accidentally combined all these drugs and reached toxic levels.

It's a safety trap just waiting for an unsuspecting patient.

And we have to mention the major cardiac safety alert.

Some of these antihistamines can prolong the QT interval on an EKG.

So in patients with a history of arrhythmias, you have to be extremely cautious.

Wow.

So it's not just about being sleepy.

No.

We're talking about the risk of fatal cardiac arrhythmias.

It's serious.

And beyond that, the more common side effects are all related to those anti -cholinergic properties.

The drowsiness, the dry mouth, GI upset, and importantly, urinary hesitancy.

Which leads to some really practical nursing tips.

If you can, give it on an empty stomach to help absorption.

Suggest sugarless candies for the dry mouth.

And have the patient try to void before each dose to minimize that urinary retention problem.

That's a great tip.

It really helps.

Okay.

So we're shifting gears for our last section.

We've talked about stopping coughs and drying things up.

Now we're talking about actively clearing out thick secretions with expectorance and mucolytics.

Exactly.

We're moving from suppressing to expelling.

So expectorance, which is mostly guifinescent, work by making the cough more productive.

How does it do that?

It's pretty clever.

It reduces the adhesiveness and surface tension of the secretions in your lower respiratory tract.

It basically just thins the mucus so you can cough it up and out.

But the key safety warning is don't use it for more than a week.

Right.

If that cough is still there after a week, it could be masking something much more serious that needs to be checked out.

And then we have the mucolytics.

Acetylcysteine and dornase alpha.

These are for a really high -risk patient.

COPD, cystic fibrosis, pneumonia, people with that thick, tenacious mucus that just won't move.

Acetylcysteine is a fascinating one.

It has that dual action.

It does.

Primarily for breathing, it works by splitting the disulfide bonds that hold the mucus together.

It literally breaks it apart.

It's also the antidote for acetaminophen overdose.

It is.

Used orally, it protects the liver from Tylenol toxicity, a very versatile drug.

Dornase alpha, on the other hand, is highly specialized.

It's used for cystic fibrosis because the mucus in CF patients is full of extracellular DNA, and this drug specifically breaks that down.

So for nursing care with dornase alpha.

You have to stress that it's palliative.

It helps, but they must continue all their other therapies, like chest physiotherapy.

It's not a cure.

And a quick practical note on administering acetylcysteine.

If it's given by face mask, you have to wipe the residue off the patient's skin right away.

Yes, with plain water.

That residue is sticky and can cause skin irritation and breakdown if you leave it on.

So to pull it all together, we've covered our five tools.

Antictissives to suppress,

decongestants to vasoconstrict, antihistamines to block the allergy,

expectorants to make coughs productive, and mucolytics to break down the tough stuff.

And the absolute core takeaway for everyone listening has to be the responsibility that comes with OTC products.

Almost all these cold and allergy remedies are combinations of these drugs.

An antihistamine with pseudoephedrine, an antitussive with an expectorant.

So patients must read the labels.

They have to know what they're taking to avoid that accidental overdose, just like in that KE scenario.

And my final thought to build on that idea of vigilance goes back to those

The fact that a local topical spray can suppress the immune response enough that we need to warn patients to avoid systemic infections like chicken pox.

That's a powerful lesson.

It shows how a seemingly simple treatment connects directly to a patient's broader health and safety in their everyday life.

That connection requires continuous vigilance from us.

That's a fantastic point.

It's a crucial perspective.

Go apply this knowledge, read those labels, and we'll catch you on the next deep dive.

β“˜ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Pharmacological management of upper respiratory tract conditions involves multiple drug classes designed to address symptoms such as cough, nasal congestion, inflammation, and excessive secretion production. Antitussives suppress the cough reflex through two distinct mechanisms: central agents like codeine and dextromethorphan work by depressing the medullary cough center in the brain, while peripheral agents such as benzonatate numb the respiratory passages through local anesthetic action. These medications require careful consideration because suppressing cough can be harmful when airway clearance is necessary, and they frequently cause undesirable central nervous system effects including sedation and drowsiness. Decongestants reduce nasal swelling and secretions by constricting blood vessels in the nasal mucous membranes. Topical formulations like oxymetazoline and tetrahydrozoline work rapidly but pose significant risks with extended use, as patients may develop rebound congestion or medicamentous rhinitis upon discontinuation. Oral decongestants such as pseudoephedrine offer systemic circulation but increase the likelihood of adrenergic side effects like elevated blood pressure, anxiety, and tremor, necessitating caution in patients with cardiovascular or endocrine conditions. Intranasal corticosteroids including fluticasone and flunisolide produce anti-inflammatory effects at the site of application and serve as first-line therapy for allergic rhinitis, though their therapeutic benefit requires several weeks to manifest fully, and their immunosuppressive properties demand careful use when active infections are present. Antihistamines work by blocking histamine-1 receptors to manage allergic manifestations, with first-generation drugs producing substantial sedation and anticholinergic responses, while newer second-generation options minimize sedative effects. Serious cardiac complications including fatal arrhythmias have been documented with antihistamine use in patients with compromised cardiac conduction, particularly those with extended QT intervals. Expectorants such as guaifenesin facilitate productive coughing by decreasing mucus thickness, whereas mucolytics including acetylcysteine and dornase alfa directly degrade mucus structure and are reserved for high-risk populations with persistent thick secretions, such as patients with cystic fibrosis or chronic obstructive pulmonary disease. Critical nursing responsibilities include patient education about reading combination medication labels to prevent accidental overdose from duplicate active ingredients and vigilant monitoring across all age groups for neurological adverse effects.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML β™₯